Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4 Pt 2
|
pubmed:dateCreated |
1982-7-19
|
pubmed:abstractText |
We assessed the modulation of gene expression accompanying neoplastic transformation by computerized microdensitometry of autoradiographic patterns of [35S]-methionine-labeled polypeptides separated by two-dimensional polyacrylamide gel electrophoresis. Nearly 1000 polypeptide species of parent diploid human fibroblasts (KD strain) and clonally-derived malignant fibroblasts (HUT-14 strain) were compared. We found that the neoplastic HUT-14 fibroblasts express a mutation in one of the two functional beta-actin genes. In addition, of the 700 more-abundant polypeptides measured, 13 were lost and 14 new ones gained after this neoplastic transformation. We estimate that although 2% of fewer of the genes expressing abundant polypeptides were either activated or shut off, at least 32% were modulated quantitatively. A substrain of HUT-14--HUT-14T--shows increased tumorigenicity, producing larger, faster-growing fibrosarcomas in the nude mouse than does the present parent HUT-14 strain, and with fewer inoculated cells. This increase in tumorigenicity is accompanied by three subsequent changes in the mutant beta-actin polypeptide expression. A more variant mutant actin species is synthesized in HUT-14T, which differs from the original mutant polypeptide by (i) one additional negative net charge, (ii) a short half-life in the cell, (iii) a greatly diminished ability to incorporate into the detergent-resistant cytoskeleton, (iv) a decrease in affinity for deoxyribonuclease I (EC 3.1.21.1), and (v) a faster rate of synthesis. Our results suggest that a second-site mutation in the mutant beta-actin of HUT-14 was selected for during a subcloning step in the presence of 6-thioguanine before derivation of the HUT-14T substrain. This apparent mutation and two subsequent defective beta-actin expressions are accompanied by incremental increases of malignant potential.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0009-9147
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
850-60
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7074877-Actins,
pubmed-meshheading:7074877-Animals,
pubmed-meshheading:7074877-Cell Line,
pubmed-meshheading:7074877-Cell Transformation, Neoplastic,
pubmed-meshheading:7074877-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:7074877-Fibrosarcoma,
pubmed-meshheading:7074877-Gene Expression Regulation,
pubmed-meshheading:7074877-Humans,
pubmed-meshheading:7074877-Isoelectric Focusing,
pubmed-meshheading:7074877-Mice,
pubmed-meshheading:7074877-Mice, Nude,
pubmed-meshheading:7074877-Models, Genetic,
pubmed-meshheading:7074877-Mutation,
pubmed-meshheading:7074877-Sarcoma, Experimental
|
pubmed:year |
1982
|
pubmed:articleTitle |
Actin mutations in a human fibroblast model for carcinogenesis.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|